Raymond Dwek
Director/Board Member bij UNITED THERAPEUTICS CORPORATION
Vermogen: 402 010 $ op 31-03-2024
Profiel
Raymond Allen Dwek is the founder of Oxford GlycoSciences Plc, which was founded in 1988.
He is currently an Independent Director at United Therapeutics Corp.
since 2002.
Mr. Dwek's former jobs include Chairman-Technology & Society at The Library of Congress, Director-Emeritus at Oxford Glycobiology Institute from 1988 to 2021, Professor & Head-Biochemistry Department at the University of Oxford from 1966 to 2009, and President at Institute of Biology from 2008 to 2010.
Mr. Dwek's education includes undergraduate and graduate degrees from the University of Oxford.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
22-04-2024 | 1 750 ( 0.00% ) | 402 010 $ | 31-03-2024 |
Actieve functies van Raymond Dwek
Bedrijven | Functie | Begin |
---|---|---|
UNITED THERAPEUTICS CORPORATION | Director/Board Member | 01-01-2002 |
Eerdere bekende functies van Raymond Dwek
Bedrijven | Functie | Einde |
---|---|---|
Oxford Glycobiology Institute | Director/Board Member | 01-01-2021 |
Institute of Biology | President | 01-01-2010 |
University of Oxford | Corporate Officer/Principal | 01-01-2009 |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Director/Board Member | 01-01-2003 |
The Library of Congress (District of Columbia) | Corporate Officer/Principal | - |
Opleiding van Raymond Dwek
University of Oxford | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
The Library of Congress (District of Columbia) | Government |
Institute of Biology |